RxDoctor Payments Data

Chelsea Minert, PA

Physician Assistant · Omaha, NENPI 1730546359

Payments from drug & device makers

$2,844in general payments, 2019–2025

Across 154 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$817
  • AstraZeneca$335
  • Amgen$244
  • Travere Therapeutics, Inc.$225
  • Mallinckrodt Hospital Products Inc.$225
  • Otsuka America Pharmaceutical, Inc.$214
  • plus $785 from 12 others

What the payments were for

  • Food & beverage$2,74496%
  • Education$1004%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,844 in reported general payments places this provider in the 85th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Medicare billing

Part B allowed, 2024
$52,771
Medicare patients
303
Services billed
767

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
KerendiaFinerenone57$46,248
FarxigaDapagliflozin Propanediol44$22,582
LokelmaSodium Zirconium Cyclosilicate14$13,156
VeltassaPatiromer Calcium Sorbitex12$10,704
Midodrine Hcl16$1,870
Bumetanide46$1,536
Potassium Chloride76$1,446
Calcitriol102$1,188
Torsemide26$554
Furosemide120$453
Losartan Potassium77$384
Amlodipine Besylate73$346
Lisinopril79$339
Hydralazine Hcl37$209
Carvedilol37$201

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
BayerKerendia$817$46,24857 claims
AstraZenecaFarxiga, Lokelma$335$35,73958 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,127 physician assistant providers in Nebraska.

Other physician assistant in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →